Advertisement
U.S. Markets close in 1 hr 55 mins

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)

BSE - BSE Real Time Price. Currency in INR
459.40-27.05 (-5.56%)
At close: 03:28PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 12.88B
Enterprise Value 11.49B
Trailing P/E 64.52
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.22
Price/Book (mrq)6.87
Enterprise Value/Revenue 5.51
Enterprise Value/EBITDA 35.57

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3499.60
52 Week Low 3270.05
50-Day Moving Average 3413.39
200-Day Moving Average 3355.97

Share Statistics

Avg Vol (3 month) 39.52k
Avg Vol (10 day) 314.49k
Shares Outstanding 526.48M
Implied Shares Outstanding 6N/A
Float 85.9M
% Held by Insiders 171.81%
% Held by Institutions 11.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 45
Forward Annual Dividend Yield 41.03%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 40.87
Payout Ratio 466.31%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 06, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 9.67%
Operating Margin (ttm)14.92%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.1B
Revenue Per Share (ttm)78.46
Quarterly Revenue Growth (yoy)2.10%
Gross Profit (ttm)N/A
EBITDA 241.98M
Net Income Avi to Common (ttm)203.13M
Diluted EPS (ttm)7.54
Quarterly Earnings Growth (yoy)-28.70%

Balance Sheet

Total Cash (mrq)1.48B
Total Cash Per Share (mrq)53.85
Total Debt (mrq)89.41M
Total Debt/Equity (mrq)4.77
Current Ratio (mrq)N/A
Book Value Per Share (mrq)69.17

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A